Toronto, July 2, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, France, and Austria, with an option to expand distribution throughout Europe. Under the terms of the agreement, DynamiCARE will pay an initial fee of CDN $2.5 million, with a ...
Toronto, April 16, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) ("Biosign" or the "Company"), and DLF Solutions Inc. (DLF), today announced they have signed a binding Heads of Agreement to enter into a Master Distribution Agreement to distribute Biosign products in Canada through DLF Solutions ...
Toronto, March 17, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) (the "Company" or "Biosign") today announced it has received notification that NexgenRx will include Biosign's UFIT(R) device and services into their Benefits Plans for reimbursement according to regulatory clearances in the relevant jurisdiction. Ronald C. Louks, President & CEO of NexgenRx, said: "We see diabetic plan members ...
Toronto (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) ("Biosign" or the "Company") today announced it has been assessed and certified as meeting the requirements of ISO 9001:2008, ISO 13485-2003, and Directive 93/42/EEC ("CE Mark") for automated wrist blood pressure and blood glucose monitors with computer controls. The certificates allow Biosign to add non-invasive blood glucose monitoring to its offerings ...